Skip to content

Clinical trials

Scleroderma, Diffuse trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Diffuse Country / region: Spain Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20151
20171
20191
20214
20223
20233
20243
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Active, not recruiting6
Completed6
Terminated3
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
GlaxoSmithKline2
Novartis Pharmaceuticals2
Artiva Biotherapeutics, Inc.1
Asociación Española de Esclerodermia1
AstraZeneca1
Bristol-Myers Squibb1
CRISPR Therapeutics1
CSL Behring1
Certa Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Diffuse24
Scleroderma, Systemic12
Lung Diseases, Interstitial6
Arthritis, Rheumatoid4
Autoimmune Diseases3
Connective Tissue Diseases3
Myositis3
Immune System Diseases2
Lupus Erythematosus, Systemic2
Lupus Nephritis2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.